Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.61B |
| 2 |
Microsoft
MSFT
|
+$1.17B |
| 3 |
Broadcom
AVGO
|
+$366M |
| 4 |
Merck
MRK
|
+$343M |
| 5 |
Meta Platforms (Facebook)
META
|
+$260M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$609M |
| 2 |
CMA
Comerica
CMA
|
+$512M |
| 3 |
CADE
Cadence Bank
CADE
|
+$422M |
| 4 |
Johnson & Johnson
JNJ
|
+$331M |
| 5 |
Western Digital
WDC
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.81% |
| 2 | Financials | 17.07% |
| 3 | Industrials | 12.54% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Healthcare | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEWP
3176
New Pacific Metals
NEWP
$833M
| $50.5K | ﹤0.01% |
12,208
-11,900
| -49% | -$48.3K |
|
3177
Southland Holdings
SLND
$33.6M
| $50K | ﹤0.01% |
36,509
-7,306
| -17% | -$13.1K |
|
3178
Empire Petroleum
EP
$101M
| $45.1K | ﹤0.01% |
15,170
+706
| +5% | +$2.17K |
|
3179
Tenaya Therapeutics
TNYA
$168M
| $44.9K | ﹤0.01% |
64,904
-5,574
| -8% | -$4.11K |
|
3180
Getty Images
GETY
$184M
| $43.8K | ﹤0.01% |
55,216
| – | – |
|
3181
T Stamp
IDAI
$10.6M
| $43.7K | ﹤0.01% |
+18,300
| New | +$57.1K |
|
3182
Inuvo
INUV
$16M
| $42.5K | ﹤0.01% |
20,542
-164
| -0.8% | -$401 |
|
3183
KLX Energy Services
KLXE
$44.8M
| $42.4K | ﹤0.01% |
+16,311
| New | +$41.2K |
|
3184
Tandy Leather Factory
TLF
$19.5M
| $41.7K | ﹤0.01% |
18,033
-1,058
| -6% | -$2.85K |
|
3185
Energy Vault
NRGV
$522M
| $41.3K | ﹤0.01% |
12,530
-10,000
| -44% | -$41.3K |
|
|
FORA
3186
DELISTED
Forian
FORA
| $40.3K | ﹤0.01% |
19,468
-1,170
| -6% | -$2.44K |
|
3187
Sera Prognostics
SERA
$80.3M
| $39.3K | ﹤0.01% |
19,535
-3,399
| -15% | -$8.76K |
|
3188
Biomea Fusion
BMEA
$90.4M
| $38.6K | ﹤0.01% |
25,339
| – | – |
|
3189
Barnwell Industries
BRN
$15.4M
| $37.9K | ﹤0.01% |
35,085
-18,619
| -35% | -$20.5K |
|
3190
Pyxis Oncology
PYXS
$165M
| $37.8K | ﹤0.01% |
25,912
-24,154
| -48% | -$36.4K |
|
3191
Actinium Pharmaceuticals
ATNM
$27M
| $34.8K | ﹤0.01% |
34,923
| – | – |
|
3192
Alpha Teknova
TKNO
$266M
| $33.1K | ﹤0.01% |
11,613
-139
| -1% | -$391 |
|
3193
Cibus
CBUS
$130M
| $32.8K | ﹤0.01% |
+16,569
| New | +$42.7K |
|
3194
RLX Technology
RLX
$2.48B
| $32.1K | ﹤0.01% |
+14,569
| New | +$33.5K |
|
3195
Vista Gold
VGZ
$253M
| $31.6K | ﹤0.01% |
16,168
| – | – |
|
3196
Equillium
EQ
$157M
| $30.7K | ﹤0.01% |
+15,333
| New | +$25.2K |
|
3197
PodcastOne
PODC
$115M
| $30.1K | ﹤0.01% |
+14,759
| New | +$37.3K |
|
|
DBGI
3198
Digital Brands Group
DBGI
$7.41M
| $28.7K | ﹤0.01% |
+398
| New | +$107K |
|
|
TGEN
3199
Tecogen Inc
TGEN
$96.3M
| $28.6K | ﹤0.01% |
+11,163
| New | +$41K |
|
3200
Acrivon Therapeutics
ACRV
$68.5M
| $25.4K | ﹤0.01% |
18,364
| – | – |
|
Similar funds
Dimensional Fund Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Dimensional Fund Advisors held 3,312 positions worth $481B, up 0.98% from $477B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q1 2026 filing shows 72 new, 1,935 increased, 1,135 reduced and 97 closed positions. Its largest new stake was Versant Media Group: 1,127,961 shares worth $41.7M. The largest sale was AstraZeneca, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2026 buy was Versant Media Group: 1,127,961 shares worth $41.7M.
- Dimensional Fund Advisors added most to Amazon in Q1 2026, an estimated $1.61B increase.
- Dimensional Fund Advisors's biggest Q1 2026 reduction was Johnson & Johnson, cutting an estimated $331M.
- Dimensional Fund Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $609M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $481B portfolio in Q1 2026.
- Dimensional Fund Advisors opened 72 new positions and closed 97 in Q1 2026.
- Dimensional Fund Advisors's portfolio value rose 0.98% quarter-over-quarter to $481B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.